Page 1334 - Clinical Immunology_ Principles and Practice ( PDFDrive )

CHaPtEr 95 Assessment of Human Allergic Diseases 1295

67. Yunginger JW, Nelson DR, Squillace DL, et al. laboratory investigation of blood histamine release in honeybee and yellow jacket venom allergy.
deaths due to anaphylaxis. J Forensic Sci 1991;35:857–65. J Invest Allergy Clin Immunol 1997;7:217–24.
68. Miller JS, Schwartz LB. Tryptase levels as an indication of mast cell 76. Moneret-Vautrin DA, Sainte-Laudy J, Kanny G, et al. Human basophil
activation in a patient with Hymenoptera anaphylaxis and mastocytosis. activation as measured by CD63 expression and LTC4 release in
N Engl J Med 1987;316:1622. IgE-mediated food allergy. Ann Allergy Asthma Immunol 1999;82:33.
69. Ruëff F, Przybilla B, Biló MB, et al. Predictors of severe systemic 77. Bochner BS, Sterbinsky SA, Saini SA, et al. Studies of cell adhesion and
anaphylactic reactions in patients with Hymenoptera venom allergy: flow cytometric analyses of degranulation, surface phenotype and
importance of baseline serum tryptase-a study of the EAACI Interest viability using human eosinophils, basophils and mast cells. Methods
Group on Insect Venom Hypersensitivity. J Allergy Clin Immunol 1997;13:61–8.
2009;124:1047. 78. Sanz ML, Gamboa PM, Antepara I. Flow cytometric basophil activation
70. Lichtenstein LM, Osler AG. Studies on the mechanisms of test by detection of CD63 expression in patients with immediate-type
hypersensitivity phenomenon. IX. Histamine release from human reactions to beta lactam antibiotics. Clin Exp Allergy 2002;32:277–86.
leukocytes by ragweed pollen. J Exp Med 1964;120:507. 79. Mangodt EA, Van Gasse AL, Decuyper I, et al. In vitro diagnosis of
71. Siraganian RP. Automated histamine analysis for in vitro allergy testing. immediate drug hypersensitivity: should we go with the flow? [Review].
II. Correlation of skin test results with in vitro whole blood histamine Int Arch Allergy Immunol 2015;168:3–12.
release in 82 patients. J Allergy Clin Immunol 1977;59:214. 80. Buhring HJ, Sieffert M, Giesert C. The basophil activation marker defined
72. Ito K, Sato S, Urisu A, et al. An evaluation of spontaneous histamine by antigen 97A6 is identical to ectonucleotide pyrophosphate/
release and the low responders in a basophil histamine release test. phosphodiesterase 3. Blood 2001;97:3303–5.
Arerugi 2016;65:48–56. 81. Platz I, Binder M, Marxer A, et al. Hymenoptera venom induced up
73. Wegner F, Hockamp R, Rutschke A, et al. Superiority of the histamine regulation of basophil activation marker ecto-nucleotide
release test above case history, prick test and radioallergosorbent test in pyrophosphatase/phosphoesterase 3 (E-NNP3, CD203c) in sensitized
predicting bronchial reactivity to the house dust mite in asthmatic individuals. Int Arch Allergy Immunol 2001;126:335–42.
children. Klin Wochenschr 1983;61:43. 82. Ebo DG, Hagendorens MM, Bridts CH, et al. In vitro allergy diagnosis:
74. de Weck AL. Cellular allergen stimulation test (CAST): a new dimension should we follow the flow? [Review]. Clin Exp Allergy 2004;34:332–9.
in allergy diagnostics. ACI News 1993;1:9–14. 83. Hoffmann HJ, Santos AF, Mayorga C, et al. The clinical utility of basophil
75. Maly FE, Marti-Wyss S, Blumber S, et al. Mononuclear blood cell activation testing in diagnosis and monitoring of allergic disease. Allergy
sulpholeukotriene generation in the presence of interleukin 3 and whole 2015;70:1393–405.